Prosecution Insights
Last updated: October 27, 2026

John D Mcanany, USPTO Patent Examiner

Listed by the USPTO as MCANANY, JOHN D

Tech Center 1600 • Art Units: 1625 1629 1699

This examiner grants 65% of resolved cases

Analysis

MCANANY, JOHN D handles cases in Tech Center 1600 and Art Unit 1625. The profile contains 63 resolved cases, with a 65.1% allowance rate and a median of 1232 days to allowance. The limited case volume makes the figures more sensitive to individual prosecution outcomes than a larger record, so practitioners should use them as directional indicators.

The interview lift is 46.4%, a positive association that makes interview preparation a potentially important consideration in this record. The listed organizations are Mayo Foundation for Medical Education and Research, The University Court of the University of Edinburgh, and Northwestern University. The associated firms are TROUTMAN PEPPER LOCKE LLP, FOLEY & LARDNER LLP, and The Roy Gross Law Firm, LLC.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

65.1%
Allow Rate
+5.1% vs TC avg
103
Total Applications
+46.4%
Interview Lift
1232
Avg Prosecution Days
Based on 63 resolved cases, 2023–2026

Rejection Statute Breakdown

1.4%
§101 Eligibility
22.9%
§102 Novelty
32.7%
§103 Obviousness
29.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17271981 METHODS OF DETERMINING TREATMENT CONSISTING OF RADIATION THERAPY AND/OR ALKYLATING CHEMOTHERAPY IN PATIENTS SUFFERING FROM CANCER Final Rejection MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
18572447 INDOCARBOCYANINE LIPID DERIVATIVES FOR IN VIVO CARGO DELIVERY Final Rejection NORTHWESTERN UNIVERSITY
18547462 2-SUBSTITUTED BICYCLO[1.1.1]PENTANES Non-Final OA The Trustees of Princeton University
18333872 REPURPOSED COMPOUND AS THERAPEUTIC FOR HPV-ASSOCIATED CANCERS Non-Final OA The Chinese University of Hong Kong
18037751 INHIBITORS OF IGF2BP1-RNA BINDING Final Rejection THE PENN STATE RESEARCH FOUNDATION
18784840 PROANGIOGENIC PROTEIN COCKTAILS DELIVERED IN CUSTOM BIOMATERIALS TO REVASCULARIZE ISCHEMIC TISSUE Non-Final OA Brown University
18826792 COMPOSITIONS AND METHODS FOR ENHANCING KRAS INHIBITOR OR SHP2 INHIBITOR EFFICACY Non-Final OA New York University

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner John D Mcanany's allowance rate?

65.1% of resolved applications examined by John D Mcanany were allowed (63 resolved cases), compared with 51.6% across Art Unit 1625 over the last five years.

Does an interview help with examiner John D Mcanany?

This examiner's interview lift is +46.4 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner John D Mcanany take to allow a patent?

Applications allowed by John D Mcanany took 1,232 days on average from filing to allowance.

Which art unit does examiner John D Mcanany work in?

John D Mcanany examines applications in Art Unit 1625 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month